You are here
AURITEC PHARMACEUTICALS, INC.
UEI: QX8KP6JKQ2L8
# of Employees: 6
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Sustained release acyclovir for prophylaxis of genital herpes
Amount: $223,952.00DESCRIPTION (provided by applicant): The broad long term goal of this project is to empower women to protect themselves from HSV and HIV infection through the development of an HSV microbicide based o ...
SBIRPhase I2009Department of Health and Human Services National Institutes of Health -
Sustained Release Inner Ear Delivery of Corticosteroid
Amount: $99,550.00DESCRIPTION (provided by applicant): The long term goal of this research is to reduce or eliminate deafness due to certain diseases of the inner ear by developing sustained release formulations for an ...
SBIRPhase I2007Department of Health and Human Services National Institutes of Health -
Sustained release calcineurin inhibitors for the prevention of graft rejection
Amount: $99,120.00DESCRIPTION (provided by applicant): The long term goal of this research is to reduce toxicity and graft rejection due to dosing problems with the calcineurin inhibitors by developing sustained releas ...
SBIRPhase I2007Department of Health and Human Services National Institutes of Health -
Sustained Release Apomrophine for Parkinson's Disease
Amount: $326,938.00DESCRIPTION (provided by applicant): The broad long term goal of this work is to develop sustained release subcutaneous drug delivery systems in order to achieve a more continuous dopaminergic stimula ...
SBIRPhase II2007Department of Health and Human Services National Institutes of Health -
Sustained release depot pre-exposure prophylaxis in breast feeding populations
Amount: $775,307.00DESCRIPTION (provided by applicant): The broad long term goal of this project is to prevent mother to child transmission of HIV through breast feeding in resource poor countries. In the developing wor ...
SBIRPhase II2006Department of Health and Human Services National Institutes of Health -
Sustained Release Intravitreal Corticosteroid Injections
Amount: $99,368.00DESCRIPTION (provided by applicant): The long term goal of this research is to reduce or eliminate blindness due to diseases of the back of the eye by developing sustained release intravitreal injecta ...
SBIRPhase I2006Department of Health and Human Services National Institutes of Health -
Prevention of HIV Transmission in Breast Feeding Populations
Amount: $83,975.00DESCRIPTION (provided by applicant): The broad long term goal of this project is to prevent mother to child transmission of HIV through breast feeding in resource poor countries. In the developing wo ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health -
Intra-articular sustained release steroid injections
Amount: $100,000.00DESCRIPTION (provided by applicant): The broad long-term goal of this research is to reduce morbidity due to arthritis by developing injectable long term intra-articular drug delivery systems. Intra-a ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health -
Continuous Dopaminergic Stimulation: Parkinson's Disease
Amount: $100,000.00DESCRIPTION (provided by applicant): The broad long term goal of this project is to develop sustained release subcutaneous drug delivery systems in order to achieve continuous dopaminergic stimulatio ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health -
Sustained Release Olanzapine
Amount: $100,000.00DESCRIPTION (provided by applicant): The long-term goal of this research is to minimize morbidity associated with psychotic disorders by developing injectable long-acting formulations of olanzapine (Z ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health